APA

Marotte L., Simon S., Vignard V., Dupre E., Gantier M., Cruard J., Alberge J., Hussong M., Deleine C., Heslan J., Shaffer J., Beauvais T., Gaschet J., Scotet E., Fradin D., Jarry A., Nguyen T. & Labarriere N. (20210819). Increased antitumor efficacy of PD-1-deficient melanoma-specific human lymphocytes. : Journal for immunotherapy of cancer.

Chicago

Marotte Lucine, Simon Sylvain, Vignard Virginie, Dupre Emilie, Gantier Malika, Cruard Jonathan, Alberge Jean-Baptiste, Hussong Melanie, Deleine Cecile, Heslan Jean-Marie, Shaffer Jonathan, Beauvais Tiffany, Gaschet Joelle, Scotet Emmanuel, Fradin Delphine, Jarry Anne, Nguyen Tuan and Labarriere Nathalie. 20210819. Increased antitumor efficacy of PD-1-deficient melanoma-specific human lymphocytes. : Journal for immunotherapy of cancer.

Harvard

Marotte L., Simon S., Vignard V., Dupre E., Gantier M., Cruard J., Alberge J., Hussong M., Deleine C., Heslan J., Shaffer J., Beauvais T., Gaschet J., Scotet E., Fradin D., Jarry A., Nguyen T. and Labarriere N. (20210819). Increased antitumor efficacy of PD-1-deficient melanoma-specific human lymphocytes. : Journal for immunotherapy of cancer.

MLA

Marotte Lucine, Simon Sylvain, Vignard Virginie, Dupre Emilie, Gantier Malika, Cruard Jonathan, Alberge Jean-Baptiste, Hussong Melanie, Deleine Cecile, Heslan Jean-Marie, Shaffer Jonathan, Beauvais Tiffany, Gaschet Joelle, Scotet Emmanuel, Fradin Delphine, Jarry Anne, Nguyen Tuan and Labarriere Nathalie. Increased antitumor efficacy of PD-1-deficient melanoma-specific human lymphocytes. : Journal for immunotherapy of cancer. 20210819.